Peptide Therapy Insights
Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.
Peptide Sciences Shuts Down: What Happened and What It Means
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
More in News
US Injectable Peptides Craze: What Patients Need to Know
The injectable peptides craze is sweeping the US, with many individuals experimenting for various health benefits. Learn the key facts and implications for patients.
NewsUnproven Peptides Gain Popularity: Risks and Concerns
The influence of social media is driving the popularity of unproven peptides, raising concerns among medical professionals. Discover the risks and what this means for patients.
NewsFDA Implements New Restrictions on Mass-Marketed Compounded GLP-1 Products
NewsInjectable Peptide Therapy Gains Mainstream Acceptance in 2025
NewsGLP-1 Market Growth Projected to Hit $33.26 Billion by 2030: Implications for Obesity and Diabetes Therapies
NewsNovartis and Unnatural Collaborate on Innovative Macrocyclic Peptide Therapies
NewsPeptide Therapy: Balancing Hope with Scientific Evidence
NewsNovartis Secures Licensing Agreement with UNP for Advanced Peptide Therapeutics
Stay Up to Date
New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.